Risk-Stratified Radiotherapy in Pediatric Cancer
Open Access
Abstract
While the cure rate of cancer in children has markedly improved in the last few decades, late effects continue to be a problem in survivors. Radiotherapy, which is a major component of treatment in many cancers, is one of the major agents responsible for late toxicity. In the past decade, radiotherapy has been omitted in patients achieving excellent response to chemotherapy, such as in Hodgkin lymphoma and some Wilms tumors with lung metastases. Likewise, response to chemotherapy has been used to determine whether lower doses of radiation can be delivered in intracranial germinoma and pediatric nasopharyngeal carcinoma. Molecular subtyping in medulloblastoma is currently being employed, and in WNT-pathway M0 tumors, the reduction in radiotherapy dose to the craniospinal axis and tumor bed is currently being investigated. Finally, dose escalation was recently evaluated in patients with rhabdomyosarcoma > 5 cm who do not achieve a complete response to initial 9 weeks of chemotherapy as well as for unresectable Ewing sarcoma patients to improve local control.Keywords
This publication has 114 references indexed in Scilit:
- Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology GroupCancer Medicine, 2019
- Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin LymphomaJAMA Oncology, 2019
- Prognostic factors and long‐term outcomes of childhood nasopharyngeal carcinomaCancer, 2010
- The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)Cancer, 2009
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005Cancer, 2009
- Treatment of nasopharyngeal carcinoma in children and adolescentsCancer, 2005
- Preradiation chemotherapy with methotrexate, cisplatin, 5‐fluorouracil, and leucovorin for pediatric nasopharyngeal carcinomaCancer, 2005
- Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperationMedical and Pediatric Oncology, 1998
- Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years oldMedical and Pediatric Oncology, 1997
- Radiotherapy for primary brain tumors in very young childrenCancer, 1982